scispace - formally typeset
L

Leopoldo Santos-Argumedo

Researcher at Instituto Politécnico Nacional

Publications -  133
Citations -  3544

Leopoldo Santos-Argumedo is an academic researcher from Instituto Politécnico Nacional. The author has contributed to research in topics: Antibody & B cell. The author has an hindex of 27, co-authored 128 publications receiving 3158 citations. Previous affiliations of Leopoldo Santos-Argumedo include National Institute for Medical Research & Merck & Co..

Papers
More filters
Journal ArticleDOI

Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers.

TL;DR: It is shown that CD40 engagement arrests B cell differentiation prior to plasma cell formation, and this arrest is manifested at a molecular level as a reduction in mRNA levels of secretory immunoglobulin gene products and the loss of the transcriptional regulator BLIMP-1.
Journal Article

A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels.

TL;DR: NIM-R5 induces an Ig-independent activation and proliferation of resting and activated B cells and is proposed that the p42 Ag is a glycoprotein with an important role in the regulation of B lymphocyte activation and survival.
Journal ArticleDOI

CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines

TL;DR: It is interesting that T cells expressing high levels of CD38 had a reduced, proliferative capacity but displayed an improved potential to produce interleukin‐2 and interferon‐γ, suggesting a role of this molecule during T cell activation and differentiation.
Journal Article

Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD38.

TL;DR: Northern blot analysis of the expression of this cDNA product in a variety of cell types, together with immunoprecipitation of the recombinant protein expressed in BaF3 cells, indicated that I-19 cDNA encodes not only the epitope recognized by NIM-R5 but also a protein that is indistinguishable biochemically and in terms of distribution from the murine B cell activation marker recognized by MAb.